DE3685818T2 - Immunkomplextestverfahren. - Google Patents

Immunkomplextestverfahren.

Info

Publication number
DE3685818T2
DE3685818T2 DE8686301682T DE3685818T DE3685818T2 DE 3685818 T2 DE3685818 T2 DE 3685818T2 DE 8686301682 T DE8686301682 T DE 8686301682T DE 3685818 T DE3685818 T DE 3685818T DE 3685818 T2 DE3685818 T2 DE 3685818T2
Authority
DE
Germany
Prior art keywords
immune complexes
column
sample
bound
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686301682T
Other languages
German (de)
English (en)
Other versions
DE3685818D1 (enExample
Inventor
Anil K Singhal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imre Corp
Original Assignee
Imre Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imre Corp filed Critical Imre Corp
Publication of DE3685818D1 publication Critical patent/DE3685818D1/de
Application granted granted Critical
Publication of DE3685818T2 publication Critical patent/DE3685818T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE8686301682T 1986-03-10 1986-03-10 Immunkomplextestverfahren. Expired - Fee Related DE3685818T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP86301682A EP0236606B1 (en) 1986-03-10 1986-03-10 Immune complex assay

Publications (2)

Publication Number Publication Date
DE3685818D1 DE3685818D1 (enExample) 1992-07-30
DE3685818T2 true DE3685818T2 (de) 1993-01-14

Family

ID=8195922

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686301682T Expired - Fee Related DE3685818T2 (de) 1986-03-10 1986-03-10 Immunkomplextestverfahren.

Country Status (4)

Country Link
EP (1) EP0236606B1 (enExample)
JP (1) JPS62231172A (enExample)
AT (1) ATE77700T1 (enExample)
DE (1) DE3685818T2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2657672B2 (ja) * 1987-08-11 1997-09-24 栄治 石川 超高感度特異的抗体の測定法
US5236849A (en) * 1987-08-11 1993-08-17 Eiji Ishikawa Method of high sensitivity immunoassay
CA1326814C (en) * 1987-08-11 1994-02-08 Eiji Ishikawa Method of high sensitivity immunoassay
JP2606722B2 (ja) * 1988-04-05 1997-05-07 栄治 石川 超高感度抗原物質の測定法
US5236830A (en) * 1988-11-10 1993-08-17 Eiji Ishikawa Method of assay for antigen
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
AT409801B (de) * 2000-05-31 2002-11-25 Cistem Biotechnologies Gmbh Verfahren zum screenen und isolieren von mikroorganismen, insbesondere prokaryontischer und eukaryontischer zellen, die ein antigen präsentieren
GB2395270B (en) 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
PT1889059E (pt) 2005-05-27 2009-10-01 Oncimmune Ltd Métodos de imunoensaio melhorados
US8574848B2 (en) 2006-09-13 2013-11-05 Oncimmune Ltd. Immunoassay methods
CN112379093B (zh) * 2020-10-22 2023-06-16 上海良润生物医药科技有限公司 CST-Cathepsin复合物作为肿瘤诊断标志物的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508133A (en) * 1975-05-20 1978-04-19 Technicon Instr Biological analysis
DE2836046A1 (de) * 1978-08-17 1980-02-28 Behringwerke Ag Immunologisches bestimmungsverfahren
JPS5915858A (ja) * 1982-07-16 1984-01-26 Otsuka Pharmaceut Co Ltd 腫瘍関連抗原特異的免疫複合体の測定法
JPS60192263A (ja) * 1984-03-13 1985-09-30 Teijin Ltd 免疫複合体測定用標準物質及びそれを用いた免疫複合体の測定法

Also Published As

Publication number Publication date
ATE77700T1 (de) 1992-07-15
EP0236606A1 (en) 1987-09-16
JPS62231172A (ja) 1987-10-09
DE3685818D1 (enExample) 1992-07-30
EP0236606B1 (en) 1992-06-24

Similar Documents

Publication Publication Date Title
EP0008432B1 (de) Immunologisches Bestimmungsverfahren
DE3650513T2 (de) Verzögerter immunologischer Test in fester Phase
DE3852786T2 (de) Verfahren und Vorrichtung gekennzeichnet durch eine nicht-saugfähige, Querfluss-ermöglichende Membran.
EP0280211B1 (de) Verfahren zur Bestimmung von Antikörpern
DE2902676C2 (de) Verfahren zur Analyse eines von RF oder C1q verschiedenen Antigens im Serum mittels eines Immunoassays
EP0023989B1 (de) Enzym-Immuntest zum Nachweis von Erreger-spezifischen Antikörpern und Testsatz für die Durchführung dieses Tests
DE3686474T2 (de) Diagnostische probe.
EP0032204B1 (de) Verfahren und Mittel zur immunologischen Bestimmung von Enzymen
DE69928507T2 (de) Festphasenverfahren und Testkit zur Antigen- und Antikörperbestimmung in der Blutgruppen-Serologie
EP0001223A2 (de) Mit einer Polyhydroxyverbindung beschichteten Latex, Verfahren zur Herstellung dieses Latex, immunologisches Reagenz enthaltend diesen Latex, Verfahren zur Herstellung dieses Reagenzes, Verwendung dieses Reagenzes, Bestimmungsverfahren unter Verwendung dieses Reagenzes und Reagenziengarnitur enthaltend dieses Reagenz.
US4711839A (en) Immune complex assay
EP0008682A1 (de) Mit einem Proteinmaterial beschichteter Latex, Verfahren zur Herstellung dieses Latex, immunologisches Reagenz enthaltend diesen Latex, Verfahren zur Herstellung dieses Reagenzes, Verwendung dieses Reagenzes, Bestimmungsverfahren unter Verwendung dieses Reagenzes und Reagenziengarnitur enthaltend dieses Reagenz
EP0291086B1 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten
EP0236606B1 (en) Immune complex assay
DE3218312C2 (de) Monoklonale Antikörper, Hybridoma-Zellklone, Verfahren zu ihrer Herstellung und ihre Verwendung zur Erkennung von Brustkrebs und maligner Lymphogranulomatose
DE69204718T2 (de) CA-195 ähnliches immunreaktives Antigen von menschlicher Amnionflüssigkeit.
DE69120463T2 (de) Verfahren zum Nachweis der Erythrozytenagglutination zur Feststellung der Blutverträglichkeit
EP0379216B1 (de) Verfahren und Reagenz zur Bestimmung von immunologisch nachweisbaren Substanzen
DE69229960T2 (de) Agglutierungsassays und kolloide farbstoffe verwendende testsätze
DE3887727T2 (de) Partikelstabilisierte Epitope zur Standardisierung und Kontrolle von Immuntests.
Galili et al. EA rosette formation: A simple means to increase sensitivity of the antiglobulin test in patients with anti red cell antibodies
Epstein et al. Naturally-occurring macroglobulin antibody of foetal origin in the normal human newborn
ANDERSON et al. Detection of Leukocyte Antibodies by Means of I131-Labelled, Purified Anti—Human-Globulin Antibody. Problems of Nonspecific Adsorption of Globulin by Leukocytes
DE69621915T2 (de) Anti-dns-antikörpernachweis mittels erkennung und bindung telomerischer dns-sequenzen
DE3852683T2 (de) Agglutinationstest.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee